Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4716191

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of crizotinib-resistant ALK T1151-L1152 insT mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.
Achary R,Yun JI,Park CM,Mathi GR,Lee JY,Ha JD,Chae CH,Ahn S,Park CH,Lee CO,Hwang JY,Yun CS,Jung HJ,Cho SY,Kim HR,Kim P
Bioorg Med Chem (2016) 24 : 207 -219
PubMed 26712094 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 3 8.96 9.48

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4743579 1 9.48
CHEMBL2403108 CERITINIB 4.0 1 8.77
CHEMBL4782674 1 8.64

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4743579 IC50 = 0.33 nM 9.48
CHEMBL2403108 CERITINIB IC50 = 1.7 nM 8.77
CHEMBL4782674 IC50 = 2.3 nM 8.64